Inovio Pharmaceuticals In... (INO)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Revenue 832.01K 10.26M 1.77M 7.41M 4.11M 30.48M 42.22M 35.37M 40.57M 10.46M 13.47M 4.12M 9.80M 6.14M 9.12M 2.10M 4.81M 3.47M 5.47M 1.17M 80.53K 189.52K 4.45M 5.08M 8.30M
Cost of Revenue 3.50M 5.50M 4.73M 94.25M 88.02M - - - - - - - - - - - - 225.00K 206.25K - - - 1.93M 1.46M 1.20M
Gross Profit -2.67M 4.77M -2.96M -86.83M -83.91M 30.48M 42.22M 35.37M 40.57M 10.46M 13.47M 4.12M 9.80M 6.14M 9.12M 2.10M 4.81M 3.24M 5.26M 1.17M 80.53K 189.52K 2.53M 3.62M 7.10M
Operating Income -135.23M -267.57M -301.22M -124.08M -111.11M -94.09M -83.64M -76.24M -34.28M -39.50M -19.54M -23.49M -21.64M -19.22M -13.96M -13.66M -15.90M -13.35M -15.51M -11.51M -6.63M -5.93M -5.58M -9.53M -6.90M
Interest Income 8.13M 4.78M 3.36M 3.31M 2.61M 2.26M 1.61M 1.40M 305.07K - 132.21K 166.11K - - - - 1.27M 867.07K 207.68K 247.56K 65.50K 32.32K 443.63K 556.19K 556.19K
Pretax Income -135.12M -277.65M -303.22M -162.89M -120.81M -94.80M -88.21M -73.74M -31.20M -36.14M -66.08M -19.71M -12.95M -17.71M -24.46M -13.61M -12.48M -14.48M -15.50M -0.66 -0.43 -5.91M -8.87M -10.13M -6.60M
Net Income -135.12M -287.66M -305.38M -215.09M -120.55M -96.97M -88.21M -73.74M -29.19M -36.12M -66.03M -19.67M -15.25M -17.61M -24.41M -12.97M -11.20M -12.48M -15.30M -10.97M -4.66M -5.96M -8.87M -9.60M -6.60M
Selling & General & Admin 47.58M 90.19M 53.75M 37.25M 27.20M 29.32M 28.29M 23.89M 18.06M 15.86M 13.64M 10.78M 11.99M 12.11M 13.67M 10.01M 11.08M 8.08M 5.98M 6.13M 4.57M 3.66M 6.62M 5.61M 5.50M
Research & Development 86.68M 187.65M 249.24M 94.25M 88.02M 95.26M 98.57M 88.71M 57.79M 34.10M 21.37M 17.98M 20.03M 13.26M 9.41M 5.75M 9.63M 8.51M 11.45M 6.55M 2.15M 2.47M 459.71K 6.98M 8.10M
Other Expenses -1.70M -3.86M 343.37K 3.42M 496.20K 360.80K 806.82K 127.55K 177.56K 348.14K -45.63M 1.98M - - 9.28M 4,672.50B 7,547.60B 225.00K 206.25K 5.60M 2.07M 2.28M - 566.36K 400.00K
Operating Expenses 132.56M 277.84M 302.99M 131.49M 115.22M 124.57M 126.86M 112.60M 75.86M 49.95M 35.01M 28.76M 32.02M 25.36M 23.08M 15.76M 20.71M 16.81M 17.64M 12.68M 6.71M 6.12M 7.08M 13.15M 14.00M
Interest Expense 1.22M 1.25M 1.94M 8.70M 7.95M 346.09K 4.56M 139.25K - - 88.17M - 34.28K - 10.50M - - - 3.33M - 20.48K 5.45K -20.38K 24.34K 24.34K
Selling & Marketing Expenses - - - - - - - - - - - - - - - - - - - - - - - - -
Cost & Expenses 144.77M 277.84M 302.99M 131.49M 115.22M 124.57M 126.86M 112.60M 75.86M 49.95M 35.01M 28.76M 32.02M 25.36M 23.08M 15.76M 20.71M 16.81M 17.64M 12.68M 6.71M 6.12M 9.01M 14.61M 15.20M
Income Tax - 10.01M 2.16M 52.20M -257.33K 2.17M 1.76M -4.62M -2.10M -3.72M 88.12M -8.11M -16.28M -4.08M 11.71M -741.85K -8.12M -867.07K 6.45M -537.76K -1.99M 56.78K - 638.17K -600.00K
Shares Outstanding (Basic) 22.17M 19.89M 17.40M 12.93M 8.23M 92.35M 81.78M 73.01M 68.20M 59.13M 46.09M 33.91M 31.56M 25.80M 18.68M 10.98M 10.37M 7.88M 4.75M 4.41M 3.33M 2.54M 1.73M 1.41M 1.27M
Shares Outstanding (Diluted) 22.17M 19.89M 17.40M 12.93M 8.23M 92.54M 81.92M 73.21M 68.37M 59.41M 46.09M 34.13M 31.56M 25.80M 18.68M 10.98M 10.37M 7.88M 4.75M 4.41M 3.33M 2.54M 1.73M 1.41M 1.27M
EPS (Basic) -6.09 -14.47 -17.55 -16.64 -14.65 -1.05 -1.08 -1.01 -0.43 -0.61 -1.43 -0.58 -0.48 -0.68 -1.31 -1.18 -1.08 -1.58 -3.22 -2.49 -1.4 -2.35 -5.13 -6.8 -5.21
EPS (Diluted) -6.09 -14.47 -17.55 -16.64 -14.65 -1.05 -1.08 -1.01 -0.43 -0.61 -1.43 -0.58 -0.48 -0.68 -1.31 -1.18 -1.08 -1.58 -3.22 -2.49 -1.4 -2.35 -5.13 -6.8 -5.21
EBITDA -130.39M -270.90M -296.56M -149.56M -107.34M -89.80M -84.74M -74.15M -33.37M -37.93M -19.45M -22.65M -21.64M -17.11M -13.96M -11.97M -10.19M -12.43M -11.38M -10.94M -6.05M -5.28M -5.58M -8.37M -8.97M
Depreciation & Amortization 3.50M 5.50M 4.73M 4.63M 5.52M 5.00M 3.47M 3.09M 1.92M 1.57M 2.10M 1.99M 2.01M 2.11M 1.68M 993.03K 954.64K 911.64K 799.32K 573.04K 584.41K 619.34K - 566.36K 400.00K